The CERN-MEDICIS (MEDical Isotopes Collected from ISolde) facility has delivered its first
radioactive ion beam at CERN (Switzerland) in December 2017 to support the research and …

The target material microstructure development for ISOL targets has received special
attention by the scientific community. In the past 10 years, the number of peer-reviewed …

Thulium-167 is a promising radionuclide for nuclear medicine applications with potential use
for both diagnosis and therapy (“theragnostics”) in disseminated tumor cells and small …

The IRIS group of IFIC-Valencia has developed a Compton camera prototype. The system
detectors are made of Lanthanum (III) bromide scintillator crystals coupled to silicon …

At the CERN-ISOLDE radioactive ion beam facility, thick targets are irradiated using a beam
of 1.4-GeV protons. One of ISOLDE's key features is the large choice of ion source types and …

A porous pre-sintered hexagonal boron nitride powder compact was recently developed as
target for the production of intense 11 C beams for Positron Emission Tomography-aided …

In this report we discuss the possibilities of using a charge breeding scheme based on an
Electron Beam Ion Source for beam preparation of a radioactive 11C beam for hadron …

Particle therapy relies on the advantageous dose deposition which permits to highly conform
the dose to the target and better spare the surrounding healthy tissues and organs at risk …

CERN-MEDICIS is an isotope mass separation facility dedicated to biomedical research
located in a type A work sector, receiving on average 50% of the 1.4 GeV protons delivered …

Negative ions are unique quantum systems which are of fundamental interest within the field
of atomic physics due to the importance of the electron correlation in their creation, stability …